Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 2 4Phase 3 3Phase 1/2 2Phase 2/3 1

Status

Completed 9Recruiting 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 1Margins of Excision 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × IFL protocol × Clear all
NCT03803553 2026-05-01

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Massachusetts General Hospital

Phase 3 Recruiting
400 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05008809 2025-12-12

AIO-KRK-0418

Charite University, Berlin, Germany

Phase 3 Recruiting
507 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting
364 enrolled
Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡